Commercialization: Page 119
-
PharmaVoice Team/PharmaVoice
For Art's Sake
Creative Review Each month, this department pays homage to memorable advertising and marketing campaigns. The highlighted executions have been identified by leading creative executives for their noteworthy use of copy, art, photography, whimsy, uniqueness, etc. — in combination or as single brand...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's on Your Mind -- Opinions
What’s on Your Mind Opinions Portable technologies There’s no question that travel is a component of everyone’s job. While on the road, portable tools that replace brick-and-mortar systems are a necessity. According to one statistic, there are more than 130 million handhelds and notebooks in use ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
With an estimated $40 million spent in 2002 on CRM products and services, CRM is becoming the leading driver of technology spend and strategic technology focus in the pharmaceutical industry. Industry experts, however, who spoke with PharmaVoice say more often than not, CRM technology projects fa...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
For Art's Sake
Creative Review For Art’s Sake each month, this department pays homage to memorable advertising and marketing campaigns. The highlighted executions have been identified by leading creative executives for their noteworthy use of copy, art, photography, whimsy, uniqueness, etc. – in combination or ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
A Face in the Crowd: Carrying the Bag with "Pat"
A Face in the Crowd Carrying the Bag with “Pat” One top 10 pharmaceutical company and the – everything from no-access physician offices to developing that elusive one-on-one relationship. An estimated 85,000 sales reps are now in the field, according to a new study by pharmaceutical intelligence ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Systems Marketing: Paradigm Shift in Pharmaceutical Marketing Strategy
Systems Marketing A Paradigm Shift in Pharmaceutical Marketing Strategy The opportunity for breakout returns from pharmaceutical marketing won’t come from tweaking the margins and incremental adaptations. It won’t come from creating more – more sales people, more promotion, more press releases, m...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Product Managers: CEO for a Brand
By Elisabeth Pena Product Managers CEO for A Brand With responsibilities ranging from marketing, branding, manufacturing, clinical affairs, regulatory issues, and life-cycle management, the product manager now needs to be involved in all the stages of the drug’s evolution. Brand Product managers ...
By Elisabeth Pena • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Medical Affairs-Marketing Connection
The Medical Affairs-Marketing Connection By Denise Myshko A changing regulatory environment is mandating that there is better collaboration between the medical affairs and marketing departments of pharmaceutical companies. These two groups are forging stronger relationshiPS for better product lif...
By Denise Myshko • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
What’s new New healthcare-related products, services, and companies PRA forms Global Medical and Safety Services Division The new business unit consolidates PRA’s risk-management activities across the company. PRA International, a clinical research organization, has formed Global Medical and Safe...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's on Your Mind -- Opinions
What’s new New healthcare-related products, services, and companies PRA forms Global Medical and Safety Services Division The new business unit consolidates PRA’s risk-management activities across the company. PRA International, a clinical research organization, has formed Global Medical and Safe...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Raise Your Voice -- Letters
Raise your voice Times have changed A whole new ball game I want to thank Mr. Pantello for sharing his candid thoughts with PharmaVOICE readers. Naturally, there has been a slight decrease in business over the last few years – single-digit vs. double-digit growth – but nothing near the catastroph...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Pharma Trax Sales, marketing, And R&D Trends affecting the healthcare industry Opportunities for Online Medical Education in Physicians’ Daily Practices Pharmaceutical companies planning to invest in online continuing medical education (eCME) need to assess the reasons physicians are using eC...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Cover
March 2004 CRM A strategic technology focus forging new territory with Victoria Hale Return on the Internet www.pharmavoice.com Download PDF
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
2nd Chances
2nd Chances By Elisabeth Pena For products that are not performing to expectations, a relaunch can revitalize a stale brand, highlight new clinical evidence, or give a product another chance to reach the patients it was designed to treat. With each therapy that a pharma company produces, the goal...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Technology Makes CRM Possible
Technology Makes CRM Possible By Denise Myshko The lifeblood of customer relationship management (CRM) is data. Many pharmaceutical companies are investing in CRM technology projects to capture and better analyze data related to their customers. At its most basic level, CRM is the application of ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Richard W. Ashley James White Abbott Laboratories Names New Executives Abbott Laboratories has named Richard W. Ashley to the new position of executive VP of corporate development. Abbott, Abbott Park, Ill., is a global, broad-based healthcare company devoted to the discovery, develop...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
E-Media New electronic and web-based applications, sites, and technologies NoInk Communications has released Pharma-SalesAccelerator, a new suite of applications specifically designed to improve productivity and increase performance of pharmaceutical sales organizations. NoInk partnered with Pedi...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Talent Pool Executive Appointments and Promotions in the Healthcare Industry Pharma POOL Eileen M. Lach Wyeth Fills VP, Associate General Counsel Position Wyeth has promoted Eileen M. Lach to the position of VP, corporate secretary, and associate general counsel. Wyeth, Madison, N.J., is a pharma...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Global Brand Development: Debunking The Myths and Understanding The Realities
Global Brand Development Debunking The Myths and Understanding The Realities These are not easy times in the pharmaceutical industry, particularly given pressures to increase shareholder return and value, increased focus on price and generic use, a drop off in new chemical entity approvals, and i...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Pharma trax Sales, marketing, And R&D Trends affecting the healthcare industry World Pharma Market Continues to Grow Amid Shifting Trends and Emerging Markets Though the pharmaceutical industry remains one of the most profitable and stable industries, several broad variables are leading to fu...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
For Art's Sake
Creative Review Each month, this department pays homage to memorable advertising and marketing campaigns. The highlighted executions have been identified by leading creative executives for their noteworthy use of copy, art, photography, whimsy, uniqueness, etc. – in combination or as single brand...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
-
PharmaVoice Team/PharmaVoice
Letter from the Editor
Early-stage commercial spending can top $60 million for blockbuster products, according to Cutting Edge Information. With such high commercial investments come equally elevated risks that drugs will fail to reach the market or achieve less than their full commercial potential. It is critical that...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Talent Pool Executive Appointments and Promotions in the Healthcare Industry Pharma POOL David J. Kudla Jr. Advancis Creates VP of Quality Assurance Position Advancis Pharmaceutical, a pharmaceutical company focused on developing and commercializing novel anti-infective products, has named David ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
on the cover Getting into the details of e-detailing E-detailing is slowly becoming an accepted medium for bringing new information to physicians. It holds the promise of building better relationships with prescribers and other healthcare practitioners. 8 FEATURES Connecting with the community Th...
By PharmaVoice Team • Jan. 2, 2008
Previous
